Diffuse Intrinsic Pontine Glioma clinical trials

Explore recruiting diffuse intrinsic pontine glioma clinical trials.

Recruiting diffuse intrinsic pontine glioma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Diffuse Intrinsic Pontine Glioma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication: BIOMEDE 2.0

Denmark, France, Sweden, Spain, Finland, Norway +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Multicenter, open label study using molecularly determined targeted therapies in children 3-18 years of age with DIPG (diffuse intrinsic pontine glioma- DIPG)- DIPGen

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 2 open label randomized study of radiotherapy, concomitant nimotuzumab and vinorelbine and re-irradiation at relapse versus radiotherapy and multiple elective radiotherapy courses with concomitant vinorelbine and nimotuzumab for newly diagnosed childhood and adolescence diffuse intrinsic pontine glioma (DIPG).

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Adjuvant dendritic cell immunotherapy complementing conventional therapy for pediatric patients with high-grade glioma and diffuse intrinsic pontine glioma

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase IB clinical trial to assess the safety, tolerability, and preliminary efficacy of AloCELYVIR (Mesenchymal allogenic cells + ICOVIR-5) in children, adolescent and young adults with newly diagnosed diffuse intrinsic pointine glioma (DIPG) in combination with radiotherapy or medulloblastoma in relapse/progression in monotherapy.

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

Phase Ib, non-randomized, single-arm, open-label, single-center clinical trial to evaluate the safety of the first-in-human administration of the combination of dendritic cell (DC) immunization pulsed with tumor lysate and CAR-T cells targeting IL13Ra2 in patients with newly diagnosed diffuse intrinsic pontine glioma (DIPG)

Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Diffuse Intrinsic Pontine Glioma trials by city

Diffuse Intrinsic Pontine Glioma in Toronto Diffuse Intrinsic Pontine Glioma in Vancouver Diffuse Intrinsic Pontine Glioma in Montreal Diffuse Intrinsic Pontine Glioma in Calgary Diffuse Intrinsic Pontine Glioma in Edmonton Diffuse Intrinsic Pontine Glioma in Ottawa Diffuse Intrinsic Pontine Glioma in Winnipeg Diffuse Intrinsic Pontine Glioma in Quebec City Diffuse Intrinsic Pontine Glioma in Hamilton Diffuse Intrinsic Pontine Glioma in Kitchener Diffuse Intrinsic Pontine Glioma in London Diffuse Intrinsic Pontine Glioma in Halifax Diffuse Intrinsic Pontine Glioma in New York Diffuse Intrinsic Pontine Glioma in Los Angeles Diffuse Intrinsic Pontine Glioma in Chicago Diffuse Intrinsic Pontine Glioma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease